Meta-Analysis of the Clinical Value of Danshen Injection and Huangqi Injection in Liver Cirrhosis
Open Access
- 1 January 2013
- journal article
- review article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2013, 1-8
Abstract
Objective. To evaluate the clinical value of Danshen injection and Huangqi injection for the treatment of liver cirrhosis.Methods. The Chinese Biomedical Literature Database (CBM), Chinese Scientific Journals Full-Text Database (VIP), Wanfang Database, China National Knowledge Infrastructure (CNKI), PubMed, and EMBASE database were searched to collect the literatures about the randomized controlled trials involving the treatment of liver cirrhosis with Danshen injection combined with Huangqi injection, and the data analyses were performed using RevMan 4.2 software.Results. A total of 11 studies involving 1086 patients (trials group: 554 cases, control group: 532 cases) were included in this study. Compared with those in control group, the meta-analysis showed-that the total effectiveness rate and the level of serum albumin increased, while serum total bilirubin, alanine transmninase, type III procollagen, hyaluronic acid, laminin, and type-IV collagen decreased in trials group. The Jadad score ranged from 1 to 2 and the funnel plot analysis suggests that publication bias may occur.Conclusions. Danshen injection combined with Huangqi injection may promote the curative efficacy of liver cirrhosis, which is a promising novel treatment approach. The exact outcome needs to perform rigorously designed, multicenter, and large randomized controlled trials.Keywords
Funding Information
- National Natural Science Foundation of China (81071799, CJ2012202, CE20125026, Y2012095, BL2012046)
- Science and Technology Bureau of Changzhou Municipality (81071799, CJ2012202, CE20125026, Y2012095, BL2012046)
- Science and Technology Bureau of Changzhou Municipality (81071799, CJ2012202, CE20125026, Y2012095, BL2012046)
- Provincial Public Health Bureau of Jiangsu (81071799, CJ2012202, CE20125026, Y2012095, BL2012046)
- Science and Technology of Jiangsu Province (81071799, CJ2012202, CE20125026, Y2012095, BL2012046)
This publication has 11 references indexed in Scilit:
- Astragalus Injection for Hypertensive Renal Damage: A Systematic ReviewEvidence-Based Complementary and Alternative Medicine, 2012
- Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic ReviewPLOS ONE, 2011
- Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathyJournal of Ethnopharmacology, 2011
- Hepatic Stellate Cell Activation and Hepatic Fibrosis Induced by Ischemia/Reperfusion InjuryTransplantation Proceedings, 2008
- Hepatitis B in ChinaThe Lancet, 2007
- Greater CD4 T-cell gains after one year of antiretroviral therapy are associated with lower HIV-1 pol replication capacityAIDS, 2006
- Liver fibrosisJournal of Clinical Investigation, 2005
- Global Epidemiology of Hepatitis B VirusJournal of Clinical Gastroenterology, 2004
- Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis CGastroenterology, 2002
- Advances in gene therapy of liver cirrhosis: a reviewWorld Journal of Gastroenterology, 2001